Not applicableUnknownNCT05868252What this trial is testingMolecular Analysis of the Sloane ProjectWho this might be right forDCISLCISAtypical Ductal Hyperplasia+1 more King's College London 1,500
Not applicableWithdrawnNCT03868475What this trial is testingComparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast LesionsWho this might be right forBreast FibroadenomaAtypical Ductal HyperplasiaAtypical Lobular Hyperplasia+7 more London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Early research (Phase 1)Study completedNCT03323658What this trial is testingBexarotene in Preventing Breast Cancer in Patients at High Risk for Breast CancerWho this might be right forBreast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Ductal Carcinoma In Situ+2 more National Cancer Institute (NCI) 24
Not applicableStudy completedNCT01052740What this trial is testingX-Ray Mammography Standard of Care ProtocolWho this might be right forBreast CancerInvasive CarcinomaIn Situ Carcinoma+2 more National Institutes of Health Clinical Center (CC) 108
Not applicableActive Not RecruitingNCT04496739What this trial is testingMaking Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)Who this might be right forAtypical Hyperplasia of the BreastLobular Breast Carcinoma In SituPleomorphic Lobular Breast Carcinoma In Situ SWOG Cancer Research Network 412
Not applicableStudy completedNCT00666731What this trial is testingBreast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast CancerWho this might be right forBreast CancerPrecancerous Condition University of Nebraska 4,945
Early research (Phase 1)Study completedNCT00637481What this trial is testingA Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast CancerWho this might be right forAtypical Ductal Breast HyperplasiaBreast CancerDuctal Breast Carcinoma in Situ+1 more National Cancer Institute (NCI) 66
Not applicableEnded earlyNCT03505372What this trial is testingRole of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal HyperplasiaWho this might be right forAtypical Ductal Hyperplasia Dana-Farber Cancer Institute 5
Not applicableLooking for participantsNCT05463796What this trial is testingInAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerWho this might be right forCancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more Dana-Farber Cancer Institute 5,000
Not applicableStudy completedNCT00620087What this trial is testingMolecular Breast Imaging in Women With Atypia and LCISWho this might be right forAtypical Lobular HyperplasiaAtypical Ductal HyperplasiaLobular Carcinoma in Situ Mayo Clinic 66
Not applicableStudy completedNCT02121873What this trial is testingThe Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and LavageWho this might be right forBreast CancerPreneoplastic ConditionsDuctal Carcinoma in Situ Atossa Therapeutics, Inc. 6
Large-scale testing (Phase 3)Active Not RecruitingNCT01357772What this trial is testingTrial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-upWho this might be right forCarcinoma, Intraductal, NoninfiltratingRecurrence, Local NeoplasmBreast Neoplasms+1 more Andrea DeCensi 500
Testing effectiveness (Phase 2)Ended earlyNCT04570956What this trial is testingOral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer RiskWho this might be right forBreast Atypical HyperplasiaBreast Lobular Carcinoma in SituBreast Atypical Lobular Hyperplasia+1 more Mayo Clinic 65
Testing effectiveness (Phase 2)Looking for participantsNCT05941520What this trial is testingAcolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast CancerWho this might be right forBreast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more National Cancer Institute (NCI) 80
Large-scale testing (Phase 3)Looking for participantsNCT06685978What this trial is testingEfficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary GlandsWho this might be right forHyperplasia of Mammary Glands Tasly Pharmaceutical Group Co., Ltd 430
Not applicableNot Yet RecruitingNCT07245316What this trial is testingAvoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment TrialWho this might be right forDuctal Carcinoma in Situ of the Breast Jeong Eon Lee 340
Early research (Phase 1)Study completedNCT01372644What this trial is testingBreast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle TrialWho this might be right forAtypical Ductal Breast HyperplasiaLobular Carcinoma in Situ (LCIS)Atypical Lobular Hyperplasia (ALH) of Breast NYU Langone Health 15
Not applicableStudy completedNCT00146536What this trial is testingUpstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional BiopsyWho this might be right forBreast Neoplasms Dana-Farber Cancer Institute 78
Not applicableUnknownNCT05932758What this trial is testingExcisional Vacuum-Assisted Breast BiopsyWho this might be right forAtypical Ductal HyperplasiaDuctal Carcinoma in Situ European Institute of Oncology 300
Not applicableUnknownNCT01034891What this trial is testingWomen At Risk: The High Risk Breast Cancer ProgramWho this might be right forBreast Cancer New York Presbyterian Hospital 2,000